CD44 Antikörper (FITC)
-
- Target Alle CD44 Antikörper anzeigen
- CD44
-
Reaktivität
- Maus
-
Wirt
- Ratte
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CD44 Antikörper ist konjugiert mit FITC
-
Applikation
- Immunohistochemistry (IHC), Immunocytochemistry (ICC)
- Produktmerkmale
- Rat Anti-Mouse CD44, FITC-labeled
- Immunogen
- CD44 enriched mouse LN T cells.
- Isotyp
- IgG
- Top Product
- Discover our top product CD44 Primärantikörper
-
-
- Applikationshinweise
- Immunohistochemistry, Immunocytochemistry,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Reconstitute with of H20. Mix gently, wash the sides of the vial and wait 30-60 seconds before use.Recommended
- Konzentration
- 1 mg/ml in PBS (after reconstitution).
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Lyophilized: store at 4°C. After reconstitution, if not intended for use within a month, aliquot and store at -20°C.
-
- Target
- CD44
- Andere Bezeichnung
- CD44 (CD44 Produkte)
- Hintergrund
- CD44 is a cell-surface glycoprotein that plays a role in cell-cell interactions, cell adhesion and migration. CD44 is a receptor for hyaluronic acid and also interacts with other ligands, such as osteopontin, collagens, and matrix metalloproteinases. CD44 participates in a wide variety of cellular functions such as lymphocyte activation, recirculation and homing, hematopoiesis, and tumor metastasis. CD44 and CD49d are putative activity markers and CD44 a potential novel therapeutic target in multiple sclerosis. Increased CD44 antigen is associated with relapses in non-small cell lung cancers. Synonyms: MDU2, MDU3, MIC4, CDW44, CSPG8, HCELL, HUTCH-I, Phagocytic glycoprotein I, PGP-1, Extracellular matrix receptor-III, ECMR-III, Hermes antigen, Hyaluronate receptor, Heparan sulfate proteoglycan, Epican) CDw44.
- Pathways
- Glycosaminoglycan Metabolic Process, Autophagie, Negative Regulation of intrinsic apoptotic Signaling
-